For affordable healthcare in the future, insurance companies challenge pharmaceutical companies to proof the patient's outcome. Therapy adherence in this context is an important factor as studies from the World Health Organization show that more than 50% of the patients do not adhere to a prescribed therapy. Improving this therapy adherence benefits not only the patient but also society as a whole.
This demo will show the NHS3152 and NHS3153 solutions for therapy adherence with the combination of NFC medical blister pill packs with a smartphone application.
Video below has 2 parts. The first one is related to the following demo:
The second one is for the therapy adherence referenced on this document.
Demo / product features
- Single chip solution for therapy adherence monitoring
- Supports smart blister pill packs, injection pens, pill bottles
- Easy integration into end-products